Rajiv Amin - Mar 10, 2023 Form 3 Insider Report for IMPEL PHARMACEUTICALS INC (IMPL)

Role
VP, Controller & Interim CFO
Signature
/s/ Adrian Adams as attorney-in-fact
Stock symbol
IMPL
Transactions as of
Mar 10, 2023
Transactions value $
$0
Form type
3
Date filed
3/10/2023, 03:33 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMPL No securities beneficially held 0 Mar 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMPL Stock Option (right to buy) Mar 10, 2023 Common Stock 15.5K $10.02 Direct F1
holding IMPL Stock Option (right to buy) Mar 10, 2023 Common Stock 10K $12.16 Direct F2
holding IMPL Stock Option (right to buy) Mar 10, 2023 Common Stock 7.5K $9.85 Direct F3
holding IMPL Stock Option (right to buy) Mar 10, 2023 Common Stock 12K $2.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the total shares on July 13, 2022, then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on July 13, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.
F2 The option vests as to 2.0833% of the total shares on August 22, 2021 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on July 22, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.
F3 The option vests as to 2.0833% of the total shares on February 26, 2022 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on January 26, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
F4 The option vests as to 2.0833% of the total shares on March 14, 2023 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on February 14, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney